Michele Bevilacqua

2.5k total citations · 1 hit paper
44 papers, 648 citations indexed

About

Michele Bevilacqua is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Michele Bevilacqua has authored 44 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 11 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Michele Bevilacqua's work include Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (5 papers) and Cardiovascular Disease and Adiposity (3 papers). Michele Bevilacqua is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (5 papers) and Cardiovascular Disease and Adiposity (3 papers). Michele Bevilacqua collaborates with scholars based in Italy, Austria and United Kingdom. Michele Bevilacqua's co-authors include John Hewitt, Fabio Petroni, Ashwin Paranjape, Nelson F. Liu, Kevin Lin, Percy Liang, Andrea Dalbeni, Filippo Cattazzo, Cristiano Fava and Plinio Cirillo and has published in prestigious journals such as PLoS ONE, Endocrinology and Critical Care Medicine.

In The Last Decade

Michele Bevilacqua

42 papers receiving 621 citations

Hit Papers

Lost in the Middle: How Language Models Use Long Contexts 2024 2026 2025 2024 50 100 150 200 250

Peers

Michele Bevilacqua
Sachin Garg United States
Wenqi Shi United States
Michele Bevilacqua
Citations per year, relative to Michele Bevilacqua Michele Bevilacqua (= 1×) peers Ming‐Chin Lin

Countries citing papers authored by Michele Bevilacqua

Since Specialization
Citations

This map shows the geographic impact of Michele Bevilacqua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bevilacqua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bevilacqua more than expected).

Fields of papers citing papers by Michele Bevilacqua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Bevilacqua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bevilacqua. The network helps show where Michele Bevilacqua may publish in the future.

Co-authorship network of co-authors of Michele Bevilacqua

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Bevilacqua. A scholar is included among the top collaborators of Michele Bevilacqua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Bevilacqua. Michele Bevilacqua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bevilacqua, Michele, Simone Romano, Filippo Cattazzo, et al.. (2025). Atezolizumab plus Bevacizumab does not cause subclinical cardiotoxicity evaluated by Left-Ventricular Global Longitudinal Strain. Digestive and Liver Disease. 57. S66–S66.
2.
Liu, Nelson F., Kevin Lin, John Hewitt, et al.. (2024). Lost in the Middle: How Language Models Use Long Contexts. Transactions of the Association for Computational Linguistics. 12. 157–173. 285 indexed citations breakdown →
3.
Bevilacqua, Michele, et al.. (2024). Hepatofugal portal flow is highly predictive of acute-on-chronic liver failure: A new hemodynamic patho-physiological hypothesis. Digestive and Liver Disease. 56(9). 1522–1528. 1 indexed citations
4.
Dalbeni, Andrea, Filippo Cattazzo, Antonio Vella, et al.. (2023). Interleukin-6: A New Marker of Advanced-Sarcopenic HCC Cirrhotic Patients. Cancers. 15(9). 2406–2406. 10 indexed citations
5.
Dalbeni, Andrea, et al.. (2023). Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients. Digestive and Liver Disease. 56(3). 477–483. 6 indexed citations
6.
Dalbeni, Andrea, Filippo Cattazzo, Michele Bevilacqua, et al.. (2023). The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study. PLoS ONE. 18(2). e0281813–e0281813. 4 indexed citations
7.
Bevilacqua, Michele, Francesco Dima, Filippo Cattazzo, et al.. (2023). Spur cells in liver cirrhosis are predictive of acute-on-chronic liver failure and liver-related mortality regardless of severe anaemia. Internal and Emergency Medicine. 18(5). 1397–1404. 2 indexed citations
8.
Cattazzo, Filippo, Rosa Lombardi, Michele Bevilacqua, et al.. (2022). Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension. Nutrition Metabolism and Cardiovascular Diseases. 32(12). 2839–2847. 5 indexed citations
9.
Fischer, Arabella, et al.. (2022). Stroke Volume and Arterial Pressure Fluid Responsiveness in Patients With Elevated Stroke Volume Variation Undergoing Major Vascular Surgery: A Prospective Intervention Study. Journal of Cardiothoracic and Vascular Anesthesia. 37(3). 407–414. 4 indexed citations
10.
Opfermann, Philipp, Martin Dworschak, Michele Bevilacqua, et al.. (2022). A Prospective Observational Study on Multiplate®-, ROTEM®- and Thrombin Generation Examinations Before and Early After Implantation of a Left Ventricular Assist Device (LVAD). Frontiers in Medicine. 9. 760816–760816. 6 indexed citations
11.
Bevilacqua, Michele, Filippo Cattazzo, Andrea Dalbeni, et al.. (2021). Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19–Related Disease. The American Journal of Cardiology. 165. 109–115. 4 indexed citations
12.
Dalbeni, Andrea, Alessandro Giollo, Michele Bevilacqua, et al.. (2020). Traditional cardiovascular risk factors and residual disease activity are associated with atherosclerosis progression in rheumatoid arthritis patients. Hypertension Research. 43(9). 922–928. 20 indexed citations
13.
Opfermann, Philipp, Elisabeth Simader, Michele Bevilacqua, et al.. (2020). Early sST2 Liberation after Implantation of a Left Ventricular Assist Device in Patients with Advanced Heart Failure. Journal of Immunology Research. 2020(1). 5826176–5826176. 17 indexed citations
14.
Fischer, Arabella, et al.. (2019). Evaluation of an active decision support system for hemodynamic optimization during elective major vascular surgery. Minerva Anestesiologica. 85(3). 288–297. 3 indexed citations
15.
Dalbeni, Andrea, Silvio Romano, Michele Bevilacqua, et al.. (2019). Effects of DAAs (direct-acting antivirals) on cardiac function and structure in hepatitis c (HCV) patients with low-mild liver fibrosis. Digestive and Liver Disease. 51. e58–e58.
16.
Tagetti, Angela, Alice Giontella, Michele Bevilacqua, et al.. (2019). SUBCLINICAL TARGET ORGAN DAMAGE IN A SAMPLE OF CHILDREN WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE. Journal of Hypertension. 37. e201–e201. 1 indexed citations
17.
Cirillo, Plinio, Francesco Pacifico, Francesca Ziviello, et al.. (2012). The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells. Thrombosis Research. 130(3). 403–408. 16 indexed citations
18.
Foschi, Diego, Fabio Corsi, M. Lazzaroni, et al.. (2007). Foschi D, Corsi F, Lazzorini M, et al. Treatment of morbid obesity by intraparietogastric administration of botulinum toxin: a randomized, double-blind, controlled study. 1 indexed citations
19.
20.
Bevilacqua, Michele. (1994). 8 Hyponatraemia in AIDS. Baillière s Clinical Endocrinology and Metabolism. 8(4). 837–848. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026